Literature DB >> 33317363

Susceptibility of primary human airway epithelial cells to Bordetella pertussis adenylate cyclase toxin in two- and three-dimensional culture conditions.

Maria Bianchi1, Rinu Sivarajan1, Thorsten Walles2, Stephan Hackenberg3, Maria Steinke1.   

Abstract

The human pathogen Bordetella pertussis targets the respiratory epithelium and causes whooping cough. Its virulence factor adenylate cyclase toxin (CyaA) plays an important role in the course of infection. Previous studies on the impact of CyaA on human epithelial cells have been carried out using cell lines derived from the airways or the intestinal tract. Here, we investigated the interaction of CyaA and its enzymatically inactive but fully pore-forming toxoid CyaA-AC- with primary human airway epithelial cells (hAEC) derived from different anatomical sites (nose and tracheo-bronchial region) in two-dimensional culture conditions. To assess possible differences between the response of primary hAEC and respiratory cell lines directly, we included HBEC3-KT in our studies. In comparative analyses, we studied the impact of both the toxin and the toxoid on cell viability, intracellular cAMP concentration and IL-6 secretion. We found that the selected hAEC, which lack CD11b, were differentially susceptible to both CyaA and CyaA-AC-. HBEC3-KT appeared not to be suitable for subsequent analyses. Since the nasal epithelium first gets in contact with airborne pathogens, we further studied the effect of CyaA and its toxoid on the innate immunity of three-dimensional tissue models of the human nasal mucosa. The present study reveals first insights in toxin-cell interaction using primary hAEC.

Entities:  

Keywords:  Adenylate cyclase toxin; Bordetella pertussis; IL-6; cyclic adenosine monophosphate; human respiratory epithelial cells

Mesh:

Substances:

Year:  2020        PMID: 33317363      PMCID: PMC7780358          DOI: 10.1177/1753425920979354

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  28 in total

1.  Expansion of cultures of human tracheal epithelium with maintenance of differentiated structure and function.

Authors:  Jonathan H Widdicombe; Lorne A Sachs; Joby L Morrow; Walter E Finkbeiner
Journal:  Biotechniques       Date:  2005-08       Impact factor: 1.993

Review 2.  Mucin overproduction in chronic inflammatory lung disease.

Authors:  Hans-Peter Hauber; Susan C Foley; Qutayba Hamid
Journal:  Can Respir J       Date:  2006-09       Impact factor: 2.409

Review 3.  Flow cytometry and cell sorting.

Authors:  Sherrif F Ibrahim; Ger van den Engh
Journal:  Adv Biochem Eng Biotechnol       Date:  2007       Impact factor: 2.635

4.  Nasal and bronchial airway epithelial cell mediator release in children.

Authors:  Emily J Pringle; Helen B Richardson; David Miller; Daniella S Cornish; Graham S Devereux; Garry M Walsh; Steve W Turner
Journal:  Pediatr Pulmonol       Date:  2012-09-28

5.  Induction of macrophage apoptosis by Bordetella pertussis adenylate cyclase-hemolysin.

Authors:  N Khelef; N Guiso
Journal:  FEMS Microbiol Lett       Date:  1995-12-01       Impact factor: 2.742

6.  Critical Role of Lipid Scramblase TMEM16F in Phosphatidylserine Exposure and Repair of Plasma Membrane after Pore Formation.

Authors:  Ning Wu; Vitalij Cernysiov; Dominique Davidson; Hua Song; Jianlong Tang; Shanshan Luo; Yan Lu; Jin Qian; Ivayla E Gyurova; Stephen N Waggoner; Vincent Quoc-Huy Trinh; Romain Cayrol; Ayumu Sugiura; Heidi M McBride; Jean-François Daudelin; Nathalie Labrecque; André Veillette
Journal:  Cell Rep       Date:  2020-01-28       Impact factor: 9.423

7.  Quantification of the adenylate cyclase toxin of Bordetella pertussis in vitro and during respiratory infection.

Authors:  Joshua C Eby; Mary C Gray; Jason M Warfel; Christopher D Paddock; Tara F Jones; Shandra R Day; James Bowden; Melinda D Poulter; Gina M Donato; Tod J Merkel; Erik L Hewlett
Journal:  Infect Immun       Date:  2013-02-19       Impact factor: 3.441

8.  Human barrier models for the in vitro assessment of drug delivery.

Authors:  Matthias Schweinlin; Angela Rossi; Nina Lodes; Christian Lotz; Stephan Hackenberg; Maria Steinke; Heike Walles; Florian Groeber
Journal:  Drug Deliv Transl Res       Date:  2017-04       Impact factor: 4.617

9.  RTX cytotoxins recognize beta2 integrin receptors through N-linked oligosaccharides.

Authors:  Jana Morova; Radim Osicka; Jiri Masin; Peter Sebo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-28       Impact factor: 11.205

10.  The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18).

Authors:  P Guermonprez; N Khelef; E Blouin; P Rieu; P Ricciardi-Castagnoli; N Guiso; D Ladant; C Leclerc
Journal:  J Exp Med       Date:  2001-05-07       Impact factor: 14.307

View more
  4 in total

Review 1.  Pathogenicity and virulence of Bordetella pertussis and its adaptation to its strictly human host.

Authors:  Thomas Belcher; Violaine Dubois; Alex Rivera-Millot; Camille Locht; Françoise Jacob-Dubuisson
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

2.  A Barrier to Defend - Models of Pulmonary Barrier to Study Acute Inflammatory Diseases.

Authors:  Anna Herminghaus; Andrey V Kozlov; Andrea Szabó; Zoltán Hantos; Severin Gylstorff; Anne Kuebart; Mahyar Aghapour; Bianka Wissuwa; Thorsten Walles; Heike Walles; Sina M Coldewey; Borna Relja
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

3.  Susceptibility of Human Airway Tissue Models Derived From Different Anatomical Sites to Bordetella pertussis and Its Virulence Factor Adenylate Cyclase Toxin.

Authors:  Rinu Sivarajan; David Komla Kessie; Heike Oberwinkler; Niklas Pallmann; Thorsten Walles; Agmal Scherzad; Stephan Hackenberg; Maria Steinke
Journal:  Front Cell Infect Microbiol       Date:  2021-12-23       Impact factor: 5.293

Review 4.  Biological Models of the Lower Human Airways-Challenges and Special Requirements of Human 3D Barrier Models for Biomedical Research.

Authors:  Cornelia Wiese-Rischke; Rasika S Murkar; Heike Walles
Journal:  Pharmaceutics       Date:  2021-12-08       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.